Evidence map›Paper›PMID 29074775›Full record

ArticleScience (New York, N.Y.)2017

A multistage antimalarial targets the plasmepsins IX and X essential for invasion and egress.

Paco Pino, Reto Caldelari, Budhaditya Mukherjee, Juha Vahokoski, Natacha Klages, Bohumil Maco, Christine R Collins, Michael J Blackman, Inari Kursula, Volker Heussler and 2 more

Abstract read
In one paragraph

Article in Science (New York, N.Y.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Conformational Dynamics of Plasmepsin X during Inhibitor Binding.The journal of physical chemistry. B · 2026
    Article
  6. Article
  7. Article
  8. Metabolite control of enzyme activity links stress to biosynthetic regulation.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  9. Article
  10. Frontiers in parasitology · 2026
    Article
  11. Article
  12. Molecular biology of the cell · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Paco PinoDepartment of Microbiology and Molecular Medicine, Faculty of Medicine-University of Geneva, Centre Médical Universitaire (CMU), 1211 Geneva, Switzerland. paco.pino@unige.ch dominique.soldati-favre@unige.ch.ORCID 0000-0001-9705-1389
Reto CaldelariInstitute of Cell Biology, University of Bern, 3012 Bern, Switzerland.
Budhaditya MukherjeeDepartment of Microbiology and Molecular Medicine, Faculty of Medicine-University of Geneva, Centre Médical Universitaire (CMU), 1211 Geneva, Switzerland.ORCID 0000-0002-1058-3620
Juha VahokoskiDepartment of Biomedicine, University of Bergen, Jonas Lies vei 91, 5009 Bergen, Norway.
Natacha KlagesDepartment of Microbiology and Molecular Medicine, Faculty of Medicine-University of Geneva, Centre Médical Universitaire (CMU), 1211 Geneva, Switzerland.
Bohumil MacoDepartment of Microbiology and Molecular Medicine, Faculty of Medicine-University of Geneva, Centre Médical Universitaire (CMU), 1211 Geneva, Switzerland.ORCID 0000-0001-8444-313X
Christine R CollinsMalaria Biochemistry Laboratory, The Francis Crick Institute, Mill Hill, London NW1 1AT, UK.ORCID 0000-0001-5191-7634
Michael J BlackmanMalaria Biochemistry Laboratory, The Francis Crick Institute, Mill Hill, London NW1 1AT, UK.ORCID 0000-0002-7442-3810
Inari KursulaDepartment of Biomedicine, University of Bergen, Jonas Lies vei 91, 5009 Bergen, Norway.
Volker HeusslerInstitute of Cell Biology, University of Bern, 3012 Bern, Switzerland.ORCID 0000-0001-8028-9825
Mathieu BrochetDepartment of Microbiology and Molecular Medicine, Faculty of Medicine-University of Geneva, Centre Médical Universitaire (CMU), 1211 Geneva, Switzerland.ORCID 0000-0003-3911-5537
Dominique Soldati-FavreDepartment of Microbiology and Molecular Medicine, Faculty of Medicine-University of Geneva, Centre Médical Universitaire (CMU), 1211 Geneva, Switzerland. paco.pino@unige.ch dominique.soldati-favre@unige.ch.ORCID 0000-0003-4156-2109

Funding

European Research CouncilMedical Research Council FC001043Wellcome Trust 086550
6 · The paper itself

Abstract

Regulated exocytosis by secretory organelles is important for malaria parasite invasion and egress. Many parasite effector proteins, including perforins, adhesins, and proteases, are extensively proteolytically processed both pre- and postexocytosis. Here we report the multistage antiplasmodial activity of the aspartic protease inhibitor hydroxyl-ethyl-amine-based scaffold compound 49c. This scaffold inhibits the preexocytosis processing of several secreted rhoptry and microneme proteins by targeting the corresponding maturases plasmepsins IX (PMIX) and X (PMX), respectively. Conditional excision of PMIX revealed its crucial role in invasion, and recombinantly active PMIX and PMX cleave egress and invasion factors in a 49c-sensitive manner.

Indexed as

AnimalsAntimalarialsAspartic Acid EndopeptidasesDisease Models, AnimalErythrocytesEthylaminesLiverMalaria, FalciparumMicePlasmodium falciparumAntimalarialsAspartic Acid EndopeptidasesEthylaminesplasmepsin

Identifiers

PMID29074775
PMCPMC5730047

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.